Acetylcysteine for prevention of contrast-induced nephropathy after intravascular angiography: A systematic review and meta-analysis

Acetylcysteine for prevention of contrast-induced nephropathy after intravascular angiography: A systematic review and meta-analysis

<p>Abstract</p> <p>Background</p> <p>Contrast-induced nephropathy is an important cause of acute renal failure. We assess the efficacy of acetylcysteine for prevention of contrast-induced nephropathy among patients undergoing intravascular angiography.</p> <p&g...

Full description

Bibliographic Details
Main Authors:	Bagshaw Sean M, Ghali William A
Format:	Article
Language:	English
Published:	BMC 2004-10-01
Series:	BMC Medicine
Online Access:	http://www.biomedcentral.com/1741-7015/2/38

Similar Items

Evaluation of N-acetylcysteine for the prevention of contrast-induced nephropathy
by: Sara K. Richter, et al.
Published: (2015-06-01)

Comparing the Effect of Vitamin E and N-Acetylcysteine on Prevention of Contrast-Induced Nephropathy in Diabetic Patients under Coronary Angiography
by: Mehdi Pishgahi, et al.
Published: (2021-01-01)

Comparison between theophylline, N-acetylcysteine, and theophylline plus N-acetylcysteine for the prevention of contrast-induced nephropathy
by: Morteza Arabmomeni, et al.
Published: (2015-01-01)

Effectiveness of N‐Acetylcysteine for the Prevention of Contrast‐Induced Nephropathy: A Systematic Review and Meta‐Analysis of Randomized Controlled Trials
by: Renfan Xu, et al.
Published: (2016-09-01)

Intravenous N-acetylcysteine for prevention of contrast-induced nephropathy: a meta-analysis of randomized, controlled trials.
by: Zikai Sun, et al.
Published: (2013-01-01)

Study on n-acetylcysteine in prevention in nephropathy in patients undergoing coronary angiography In HUSM
by: Mohamed, Wan Mohd lzani Wan
Published: (2011)

Rationale, design, and baseline characteristics of the Acetylcystein for Contrast-Induced nephropaThy (ACT) Trial: a pragmatic randomized controlled trial to evaluate the efficacy of acetylcysteine for the prevention of contrast-induced nephropathy
Published: (2009-06-01)

Atorvastatin and prevention of contrast induced nephropathy following coronary angiography
by: Peyman Bidram, et al.
Published: (2015-01-01)

Comparison of N-acetylcysteine, ascorbic acid, and normal saline effect in prevention of contrast-induced nephropathy
by: Arsalan Khaledifar, et al.
Published: (2015-08-01)

Trimetazidine in the prevention of contrast induced nephropathy following coronary angiography/angioplasty
by: Rabin Chakraborty, et al.
Published: (2015-12-01)

Association of N-acetylcysteine use with contrast-induced nephropathy: an umbrella review of meta-analyses of randomized clinical trials
by: Rong Zhu, et al.
Published: (2023-09-01)

Study on n-acetylcysteine in prevention of contrast nephropa thy in patients undergoing coronary angiography in HUSM
by: Yusof, Zurkurnai
Published: (2011)

The Incidence of Contrast-Induced Nephropathy and the Need of Dialysis in Patients Receiving Angiography: A Systematic Review and Meta-Analysis
by: Mei-Yi Wu, et al.
Published: (2022-04-01)

Antithrombin Ⅲ is a Novel Predictor for Contrast Induced Nephropathy After Coronary Angiography
by: Rui Wu, et al.
Published: (2018-02-01)

The Incidence of Contrast-induced Nephropathy after Computed Tomography Angiography in Orthopedic Trauma Patients
by: Jeremy D Podolnick, et al.
Published: (2017-01-01)

SGLT-2 inhibitors and prevention of contrast-induced nephropathy in patients with diabetes undergoing coronary angiography and percutaneous coronary interventions: systematic review and meta-analysis
by: Edinson Dante Meregildo-Rodriguez, et al.
Published: (2023-12-01)

The standard dose versus double dose of N-acetylcysteine to prevent contrast-induced nephropathy; a randomized controlled clinical trial
by: Rahimeh Eskandarian, et al.
Published: (2018-07-01)

Prophylactic Effect of Theophylline in Renal Contrast Nephropathy after Coronary Angiography
by: Mokhberi Vahid, et al.
Published: (2006-04-01)

Prophylactic Effect of Theophylline in Renal Contrast Nephropathy after Coronary Angiography
by: Asadollah Mohseni, et al.
Published: (2006-07-01)

Lower incidence of contrast-induced nephropathy in patients undergoing fluorescent angiography
by: Ji Hwan Lee, et al.
Published: (2017-04-01)

Preventive Effects of Sodium Bicarbonate on Contrast-induced Nephropathy in High-risk Patients Undergoing Coronary Angiography:
by: Mohammad Reza Yeganehkhah, et al.
Published: (2015-11-01)

Efficacy of alprostadil for preventing of contrast-induced nephropathy: A meta-analysis
by: Jing-Zhan Zhang, et al.
Published: (2017-04-01)

Contrast induced nephropathy: Pathophysiology and prevention
by: Sudarshan Kumar Vijay, et al.
Published: (2013-01-01)

Severe thrombocytopenia induced by iodinated contrast after coronary angiography: The use of gadolinium contrast and intravascular ultrasound as an alternative to guide percutaneous coronary intervention
by: José María Cubero-Gómez, et al.
Published: (2017-01-01)

N-acetylcysteine in the Prevention of Contrast-induced Acute Kidney Injury: a Systematic Review and Meta-analysis of Randomized Controlled Clinical Trials
by: E. M. Mezhonov, et al.
Published: (2022-09-01)

Contrast Induced Nephropathy After Brain and Cervical CT Angiography in Stroke Patients: A Prospective Study
by: Maryam Poursadeghfard, et al.
Published: (2019-08-01)

Comparison between three supportive treatments for prevention of contrast-induced nephropathy in high-risk patients undergoing coronary angiography
by: Mohammad Reza Yeganehkhah, et al.
Published: (2014-01-01)

Efficacy of Trimetazidine in the Prevention of Contrast-Induced Nephropathy in Patients Undergoing Contrast Coronary Intervention: A Systematic Review and Meta-Analysis (PRISMA)
by: Tiny Nair, et al.
Published: (2024-04-01)

Predicting contrast-induced nephropathy after CT pulmonary angiography in the critically ill: a retrospective cohort study
by: Kwok M. Ho, et al.
Published: (2018-01-01)

Evaluation of prediction score of contrast-induced nephropathy in inpatients undergone to digital or CT angiography
by: Seleno Glauber de Jesus-Silva, et al.
Published: (2020-09-01)

Dose escalation study of intravenous and intra-arterial N-acetylcysteine for the prevention of oto- and nephrotoxicity of cisplatin with a contrast-induced nephropathy model in patients with renal insufficiency
by: Edit Dósa, et al.
Published: (2017-10-01)

Contrast induced nephropathy with ultra-low contrast percutaneous coronary intervention under intravascular ultrasound guidance in patients of chronic kidney disease
by: Raushan Ranjan, et al.
Published: (2021-12-01)

Sodium bicarbonate-based hydration prevents contrast-induced nephropathy: a meta-analysis
by: Tamhane Umesh, et al.
Published: (2009-05-01)

Contrast-induced nephropathy: Pathophysiology, risk factors, and prevention
by: Mohammad A Hossain, et al.
Published: (2018-01-01)

Is Nebivolol Really Effective in Preventing Contrast Induced Nephropathy?
by: Orcun Altunoren, et al.
Published: (2015-10-01)

Contrast-induced nephropathy after computed tomography
by: Luciano da Silva Selistre, et al.
Published: (2015-03-01)

A meta-analysis of N-acetylcysteine in contrast-induced nephrotoxicity: unsupervised clustering to resolve heterogeneity
by: Star Robert A, et al.
Published: (2007-11-01)

Contrast-induced nephropathy
by: Nazar M. A. Mohammed, et al.
Published: (2013-01-01)

Contrast-induced nephropathy
by: Ricardo A. García Hernández, et al.
Published: (2016-04-01)

Contrast Induced Nephropathy
by: Nurul R Ningrum, et al.
Published: (2013-06-01)